PLENARY 3 OF ISPOR 7TH ASIA-PACIFIC CONFERENCE EXPLORES UNIVERSAL HEALTH COVERAGE IN ASEAN

Published Sep 6, 2016
Speakers Outlined Health Systems in the Region as Demand Grows  Singapore—September 6, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) third plenary session for the Society’s 7th Asia-Pacific ConferenceThe Affordable Dream in ASEAN: Experiences and Lessons Learned—was held this morning in Singapore. Ahmad Fuad Afdhal, PhD, Director, Center for Socio-Economic Studies in Pharmacy, Jakarta, Indonesia moderated the session. Speakers included:
  • Netnapis Suchonwanich, Former Deputy Secretary General, National Health Security Office (NHSO), Bangkok, Thailand
  • Syed Aljunid, MD, PhD, Professor, Health Economics and Public Health Medicine and Head, International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
  • Kun Zhao, MD, PhD, MHSc, Professor and Director, Division of Health Policy Evaluation and Technology Assessment, China National Health Development Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China
  • Graham Harrison, PhD, World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, World Health Organization (WHO), Kuala Lumpur, Malaysia
In this plenary, speakers outlined the highly divergent statuses between health systems across countries of the Association of Southeast Asian Nations (ASEAN) as demand is growing in the region. The speakers highlighted the disparate approaches in the region due to the diversity in these countries’ historical, socio-economic, cultural, and political spheres, noting that a number of countries in ASEAN are moving toward universal health coverage, while Singapore and Thailand have already achieved this goal.  Netnapis Suchonwanich reviewed the growth of health coverage in Thailand, with the achievement of universal health coverage in 2001. The country’s current focus includes efforts to cover non-Thais, improvement in provision of medicines such as vaccines and antivenin, and management of the overall health benefit package. Syed Aljunid, MD, PhD compared health spending in Malaysia to other countries in the region and described the country’s progress in achieving universal health coverage. Current health care considerations in Malaysia include decentralization of health services to local governments and use of voluntary health insurance programs. Kun Zhao, MD, PhD, MHSc discussed the many challenges involved in expanding universal health coverage across ASEAN, including the use of health technology assessment (HTA) to support affordable universal health coverage. Dr. Zhao also outlined China’s goals for the country’s Healthy China 2030 initiative. Graham Harrison, PhD examined universal health coverage within the context of the World Health Organization’s Sustainable Development Goals. Acknowledging the complex interactions of health with social, economic, and environmental issues, Dr. Harrison emphasized the importance of measurable and meaningful indicators of health in monitoring the success of universal health coverage. Plenary moderator Ahmad Fuad Afdhal, PhD summarized the session by noting, “To be appropriate, priority setting must reflect the objective of universal health coverage. In this regard, there are two primary goals. First, is to improve the overall health of the population. Second, is to bring about a more equitable distribution of health care within the population.” Additional information on the ISPOR 7th Asia-Pacific Conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORsingapore.

###

Related Stories

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×